Peter S. Klein
Director · Denali Therapeutics Inc.
Individual
- 2026
- Jun 5, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter S. Klein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
- Peter Scott Chin - $37K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter S. Klein?
Peter S. Klein is a corporate insider, tracked as Director of Denali Therapeutics Inc. (DNLI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Peter S. Klein last file a Form 4?
The only primary Form 4 on record is dated 5 June 2026.
